NYSE:PEG
NYSE:PEGIntegrated Utilities

Is PSEG Fairly Priced After Recent Grid Investment Momentum and Mixed Valuation Signals?

Wondering if Public Service Enterprise Group is quietly trading at a bargain or already priced for perfection? You are not alone, and that is exactly what we are going to unpack here. The stock is sitting around $80.65, up 2.1% over the last week but still down 2.1% over 30 days and 5.2% year to date, while longer term holders are looking at gains of 48.4% over 3 years and 66.9% over 5 years. Recent moves have been shaped by a steady drumbeat of policy, regulatory, and grid investment...
NYSE:MSGE
NYSE:MSGEEntertainment

How Radio City’s Sphere Immersive Sound Debut At Madison Square Garden Entertainment (MSGE) Has Changed Its Investment Story

Madison Square Garden Entertainment announced that Radio City Music Hall’s new Sphere Immersive Sound system, first used in the 2025 Christmas Spectacular, will power a one-night-only New York Philharmonic concert at the venue on January 25, with tickets starting at US$99 including US$24 in service charges. This pairing of cutting-edge immersive audio with a marquee cultural institution underscores MSG Entertainment’s push to differentiate its venues through technology-enhanced live...
NYSE:OUT
NYSE:OUTSpecialized REITs

OUTFRONT Media (OUT): Revisiting Valuation After a Strong Multi‑Month Share Price Rally

OUTFRONT Media (OUT) has quietly delivered a strong run lately, with the stock up about 10% this month and more than 30% over the past 3 months, outpacing many real estate peers. See our latest analysis for OUTFRONT Media. At a share price of $24.51, OUTFRONT’s recent 1 month share price return of just over 10% and robust 1 year total shareholder return near the mid 40s suggest that momentum is building as investors warm to its recovery story. If OUTFRONT’s rebound has caught your eye, this...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian Automotive (RIVN) Advances In House AI While Managing Major Recall

Rivian Automotive, listed on NasdaqGS:RIVN, has unveiled a major in-house push into artificial intelligence and autonomous driving technology, including its own custom processor and proprietary autonomy stack. The company also introduced a new subscription service for hands free driving features, while simultaneously initiating a recall of nearly 35,000 electric delivery vans to fix a seat belt safety defect. The announcements arrive as Rivian shares trade at about $17.63, with the stock up...
NYSE:CLX
NYSE:CLXHousehold Products

How ERP Rollout Disruptions and an Earnings Beat At Clorox (CLX) Has Changed Its Investment Story

Earlier this month, Clorox reported third-quarter revenue of US$1.43 billion, an 18.9% year-on-year decline that nonetheless exceeded analyst estimates, while management flagged temporary market share losses tied to the rollout of a new ERP system. The company framed the ERP launch as a key step in a broader transformation to boost execution and productivity, even as commentators like Jim Cramer highlighted the contrast between Clorox’s strong brand portfolio and its weak share price...
NYSE:AGX
NYSE:AGXConstruction

Assessing Argan (AGX) Valuation After Strong Earnings Growth and Sustained Dividend Payments

Argan (AGX) just delivered another earnings step up, with higher net income and earnings per share for both the third quarter and year to date, and supported it with a steady quarterly dividend. See our latest analysis for Argan. Despite a sharp pullback in the last month, with a 30 day share price return of minus 14.4 percent, Argan’s year to date share price return of roughly 107 percent and a 1 year total shareholder return of about 116 percent still underline strong momentum. This is...
NasdaqGS:HQY
NasdaqGS:HQYHealthcare

HealthEquity (HQY): Assessing Valuation After a Recent Pullback in a Longer-Term Growth Story

HealthEquity (HQY) has pulled back about 5% over the past month even though its revenue and net income are still growing at a healthy clip. That disconnect is what makes the stock interesting now. See our latest analysis for HealthEquity. Zooming out, the recent 1 month share price pullback sits against a steady backdrop where the share price has barely moved year to date, while the 3 year total shareholder return of more than 50% shows that longer term momentum is still very much intact. If...
NYSE:WD
NYSE:WDDiversified Financial

Is Walker & Dunlop’s 2025 Share Price Slide Creating a Long Term Opportunity?

Wondering if Walker & Dunlop is a beaten down financial stock hiding real value, or cheap for a reason? Let us unpack what the recent share price and fundamentals are really telling us. The stock closed at $61.44 recently and is down 3.3% over the last week, 0.6% over the last month, and a hefty 35.6% year to date, which will catch the eye of both bargain hunters and risk conscious investors. That slide comes against a backdrop of a challenging commercial real estate and lending environment,...
NYSE:CMRE
NYSE:CMREShipping

Costamare (NYSE:CMRE): Assessing Valuation After a 71% One-Year Share Price Surge

Costamare (CMRE) has quietly outpaced much of the shipping sector, with shares up about 19% in the past 3 months and roughly 71% over the past year, despite falling revenue. See our latest analysis for Costamare. That move reflects a market that has steadily re-rated Costamare, with the recent 1 year total shareholder return of about 71 percent reinforcing the longer term trend of strong compounding gains. If Costamare's run has you rethinking where momentum might build next, it could be...
NYSE:PMT
NYSE:PMTMortgage REITs

How Investors May Respond To PennyMac Mortgage Investment Trust (PMT) Dividend And Analyst Upgrade News

PennyMac Mortgage Investment Trust recently announced that its Board of Trustees declared a cash dividend of US$0.40 per common share for the fourth quarter of 2025, payable on January 23, 2026, to shareholders of record as of December 26, 2025. Around the same time, Keefe, Bruyette & Woods upgraded PennyMac Mortgage Investment Trust to “Outperform,” highlighting increased analyst confidence in the trust’s financial outlook and income profile. We’ll now examine how the Keefe, Bruyette &...
NasdaqGM:RUM
NasdaqGM:RUMInteractive Media and Services

Rumble (RUM) Valuation Check After Securing Exclusive Andrew Tate vs. Chase DeMoor Boxing Livestream

Rumble (RUM) just landed an attention grabbing exclusive, securing livestream rights to the Andrew Tate vs. Chase DeMoor Misfits Boxing event on Rumble Premium, a clear push to grow paying subscribers. See our latest analysis for Rumble. That push into exclusive, influencer driven events comes as Rumble’s share price has been volatile, with a 30 day share price return of 15.62 percent and a year to date share price return of negative 48.06 percent. The 1 year total shareholder return of...
NasdaqGS:NXST
NasdaqGS:NXSTMedia

Assessing Nexstar Media Group’s (NXST) Valuation After DirecTV Antitrust Case Is Revived by Appeals Court

A U.S. appeals court has revived DirecTV’s antitrust lawsuit against Nexstar Media Group (NXST), forcing the broadcaster to defend allegations of inflating retransmission fees, a turn that injects fresh legal and regulatory risk into the stock. See our latest analysis for Nexstar Media Group. Despite the legal noise, Nexstar’s share price has held up well, with a strong year to date share price return and a solid multi year total shareholder return suggesting momentum remains broadly...
NYSE:HRL
NYSE:HRLFood

Hormel Foods (HRL) Valuation Check After Justin’s Spinoff Partnership and New Enterprise CMO Strategy

Hormel Foods (HRL) just reshaped its growth playbook, spinning Justin's into a standalone partnership with Forward Consumer Partners and installing veteran marketer Jason Levine as its first enterprise-wide CMO, both aimed squarely at revitalizing brand driven growth. See our latest analysis for Hormel Foods. Despite these brand moves and fresh leadership, the stock’s 7.67% 1 month share price return only partially claws back a much weaker year to date share price performance and a multi year...
NasdaqGS:LSCC
NasdaqGS:LSCCSemiconductor

Lattice Semiconductor (LSCC): Reassessing Valuation After sensAI 8.0 Expands Its Edge AI Ambitions

Lattice Semiconductor (LSCC) just rolled out sensAI 8.0, a fresh upgrade to its edge AI stack that promises broader model support, better performance, and more flexible deployment options for industrial, automotive, and consumer applications. See our latest analysis for Lattice Semiconductor. Even with the sensAI 8.0 launch and a new $250 million share repurchase program, Lattice’s 30 day share price return of 11.07% sits alongside a more modest 23.34% one year total shareholder return. This...
NasdaqGS:OZK
NasdaqGS:OZKBanks

How Record Profit Amid Revenue Miss and Rising Institutional Stakes Could Shape Bank OZK (OZK) Investors

In the past quarter, Bank OZK reported revenue that missed analyst expectations by 7.2% but delivered record net income, earnings per share, and net interest income, while management expressed confidence about improving on 2024 results despite a shifting backdrop. At the same time, Ranger Investment Management L.P. increased its stake in Bank OZK by 8.0% to 282,940 shares, highlighting growing institutional interest even as top-line performance lagged forecasts. Against this backdrop of...
NasdaqGS:WDC
NasdaqGS:WDCTech

Western Digital (WDC): Taking Stock of Valuation as It Enters the Nasdaq-100 on Strong AI Storage Demand

Western Digital (WDC) is stepping into the Nasdaq 100 this month, a move that can draw fresh buying from index funds, even as AI driven demand keeps lifting its high capacity storage business. See our latest analysis for Western Digital. The index promotion comes after an exceptional run, with Western Digital’s share price delivering a roughly 169% year to date return and a 270% one year total shareholder return, even as the stock has recently pulled back from highs near $166. This pattern...
NasdaqCM:ONDS
NasdaqCM:ONDSCommunications

Ondas Holdings (ONDS) Is Down 18.3% After Defense Push And Dilution Risks Collide - Has The Bull Case Changed?

In recent days, Ondas Holdings has accelerated its push into defense and autonomous systems through acquisitions like Roboteam and Sentrycs, new government contracts including a multi-year autonomous border protection program, and a completed AI-powered demining pilot with Safe Pro Group in the Middle East. At the same time, boardroom changes, insider selling, and a proposed debt-and-warrant exchange that may issue up to 7.33 million new shares highlight governance and dilution questions...
NYSE:TPB
NYSE:TPBTobacco

Should Strong Q3 Results, Larger ATM Plan, and Insider Selling at Turning Point Brands (TPB) Require Action From Investors?

Turning Point Brands recently reported third-quarter earnings that surpassed market expectations, amended its at-the-market equity program by US$200 million, and confirmed a US$0.075 per-share dividend payable on 9 January 2026 following its 19 December 2025 ex-dividend date. Amid these updates, a director’s sale of 2,000 shares and a year of only insider sells add an extra layer of context for interpreting the company’s otherwise upbeat operational and capital allocation signals. Next,...
NYSE:NOV
NYSE:NOVEnergy Services

Assessing NOV’s Valuation After Barclays’ Target Hike and Brighter Wall Street Outlook

Barclays just nudged its outlook on NOV (NOV) higher by lifting its target while keeping a cautious stance, and that shift, echoed by other Wall Street upgrades, has quietly pulled more eyes to the stock. See our latest analysis for NOV. That slightly brighter backdrop lines up with NOV’s recent trading pattern. A 90 day share price return of about 21% contrasts with a still modest 1 year total shareholder return of roughly 15%, suggesting momentum is building but not yet euphoric. If this...
NYSE:IFF
NYSE:IFFChemicals

International Flavors & Fragrances (IFF): Evaluating Valuation After Recent Net Income Rebound and Stabilizing Share Performance

International Flavors & Fragrances (IFF) has been quietly trying to reset expectations after a tough stretch, showing modest revenue growth alongside a sharp rebound in annual net income growth that is catching investors attention. See our latest analysis for International Flavors & Fragrances. Despite the latest share price of $65.62 and a modest positive 90 day share price return, longer term total shareholder returns over one, three, and five years remain deeply negative. This suggests...
NasdaqCM:SGML
NasdaqCM:SGMLMetals and Mining

Sigma Lithium (SGML) Is Down 7.6% After China Cancels Legacy Lithium Licenses Has The Bull Case Changed?

China recently canceled a range of older, mostly non-operational lithium mining licenses, triggering a sharp rise in domestic lithium prices and raising concerns about future supply tightness. This potential tightening of global lithium supply is particularly important for producers like Sigma Lithium, whose business model is directly linked to lithium market conditions. We’ll now examine how the prospect of tighter lithium supply from China could reshape Sigma Lithium’s investment narrative...
NYSE:NUE
NYSE:NUEMetals and Mining

Nucor (NUE): Revisiting Valuation After Recent Share Price Pullback and Strong Year-to-Date Rally

Nucor (NUE) shares have cooled off slightly this week, even after a strong run over the past year, and that dip has some investors revisiting whether the steel maker’s momentum still looks sustainable from here. See our latest analysis for Nucor. That pullback comes after a strong stretch, with Nucor’s 30-day share price return of 8.2 percent and year to date share price return of 40.4 percent pointing to momentum that still looks more like a pause than a reversal. This is especially the case...
NasdaqGS:WFRD
NasdaqGS:WFRDEnergy Services

What Weatherford International (WFRD)'s Bet on Subsurface Biotech Means for Shareholders

Eclipse Energy previously announced a collaborative partnership with Weatherford International plc, including a capital investment from Weatherford to accelerate deployment of Eclipse’s subsurface biotechnology platform for clean hydrogen and other fuels, with joint projects targeted to begin in January 2026. This move leverages Weatherford’s global oilfield footprint to turn mature reservoirs into clean energy assets, highlighting how legacy infrastructure can be repurposed for the energy...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

First Chemotherapy-Free CD19/CD20 Lymphoma Regimen In Europe Might Change The Case For Investing In Incyte (INCY)

In mid-December 2025, Incyte announced that the European Commission approved Minjuvi (tafasitamab) with lenalidomide and rituximab for adults with relapsed or refractory Grade 1–3a follicular lymphoma after at least one prior systemic therapy. This creates the first approved CD19/ CD20 dual-targeted, chemotherapy-free immunotherapy regimen for eligible follicular lymphoma patients in Europe, meaningfully broadening Incyte’s oncology footprint in a key market. We’ll now examine how this new...